Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtröder K, Jensen JB, Strandgaard T, Nordentoft I, Christensen E, Sokac M, Birkbak NJ, Maretty L, Hermann GG, Petersen AC, Weyerer V, Grimm MO, Horstmann M, Sjödahl G, Höglund M, Steiniche T, Mogensen K, de Reyniès A, Nawroth R, Jordan B, Lin X, Dragicevic D, Ward DG, Goel A, Hurst CD, Raman JD, Warrick JI, Segersten U, Sikic D, van Kessel KEM, Maurer T, Meeks JJ, DeGraff DJ, Bryan RT, Knowles MA, Simic T, Hartmann A, Zwarthoff EC, Malmström PU, Malats N, Real FX, Dyrskjøt L. Lindskrog SV, et al. Among authors: grimm mo. Nat Commun. 2021 Apr 16;12(1):2301. doi: 10.1038/s41467-021-22465-w. Nat Commun. 2021. PMID: 33863885 Free PMC article.
Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
Sanjmyatav J, Hartmann A, Moch H, Hauke S, Gajda M, Meyer B, Pryalukhin A, Grimm MO, Junker K. Sanjmyatav J, et al. Among authors: grimm mo. Eur Urol. 2014 May;65(5):e71-2. doi: 10.1016/j.eururo.2013.12.002. Epub 2013 Dec 8. Eur Urol. 2014. PMID: 24332347 No abstract available.
Gigantic Suprapubic Lymphedema: A Case Study.
Tanhaeivash R, Franiel T, Grimm MO, Horstmann M. Tanhaeivash R, et al. Among authors: grimm mo. World J Mens Health. 2016 Aug;34(2):148-52. doi: 10.5534/wjmh.2016.34.2.148. Epub 2016 Aug 23. World J Mens Health. 2016. PMID: 27574599 Free PMC article.
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
Salomo K, Huebner D, Boehme MU, Herr A, Brabetz W, Heberling U, Hakenberg OW, Jahn D, Grimm MO, Steinbach D, Horstmann M, Froehner M, Wirth MP, Fuessel S. Salomo K, et al. Among authors: grimm mo. J Cancer Res Clin Oncol. 2017 Sep;143(9):1757-1769. doi: 10.1007/s00432-017-2433-3. Epub 2017 May 8. J Cancer Res Clin Oncol. 2017. PMID: 28484844 Clinical Trial.
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF. Dyrskjøt L, et al. Among authors: grimm mo. Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2. Eur Urol. 2017. PMID: 28583312
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.
van Kessel KEM, van der Keur KA, Dyrskjøt L, Algaba F, Welvaart NYC, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Grimm MO, Hermann GG, Mogensen K, Hartmann A, Harving N, Petersen AC, Jensen JB, Junker K, Boormans JL, Real FX, Malats N, Malmström PU, Ørntoft TF, Zwarthoff EC. van Kessel KEM, et al. Among authors: grimm mo. Clin Cancer Res. 2018 Apr 1;24(7):1586-1593. doi: 10.1158/1078-0432.CCR-17-2719. Epub 2018 Jan 24. Clin Cancer Res. 2018. PMID: 29367430
A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
Stubendorff B, Wilhelm K, Posselt K, Catto J, Hartmann A, Bertz S, Füssel S, Novotny V, Toma M, Gajda M, Lehmann J, Wunderlich H, Grimm MO, Stöckle M, Junker K. Stubendorff B, et al. Among authors: grimm mo. J Cancer Res Clin Oncol. 2019 Apr;145(4):811-820. doi: 10.1007/s00432-018-02829-4. Epub 2019 Jan 2. J Cancer Res Clin Oncol. 2019. PMID: 30603903
285 results